Medicinal Products

Dáil Éireann Debate, Wednesday - 10 July 2024

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Wednesday, 10 July 2024

Ceisteanna (283)

Robert Troy

Ceist:

283. Deputy Robert Troy asked the Minister for Health if Ireland always complies with EU Directive 89/105/EEC, which states that Member States must make a decision on the price charged and the level of reimbursement for a medicinal product within 90 days of receiving an application, provided all the necessary information is provided. [30119/24]

Freagraí scríofa

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile